PRIORIX VACCINE 0.5ML VIAL

PRIORIX 0.5ML VIAL: Your Protection Against Measles, Mumps, and Rubella

PRIORIX 0.5ML VIAL is a highly effective vaccine developed by GlaxoSmithKline (GSK) to provide active immunization against three common and potentially serious childhood diseases: Measles, Mumps, and Rubella. This live attenuated vaccine is crucial for public health, aiming to prevent outbreaks and protect individuals from the severe complications associated with these viral infections.

Available at leading pharmacies like Nahdi Online and e-commerce platforms such as and , PRIORIX offers reliable protection as part of routine immunization schedules. This 0.5mL single-dose vial is formulated for subcutaneous administration by a qualified healthcare professional.

Benefits of Use:

• Provides comprehensive protection against Measles, Mumps, and Rubella with a single vaccine.
• Helps prevent severe health complications associated with these diseases, including pneumonia, encephalitis, hearing loss, and congenital rubella syndrome.
• Contributes to herd immunity, protecting vulnerable individuals who cannot be vaccinated.
• Part of the recommended childhood immunization schedule globally.

How to Use:

1. PRIORIX is administered by a healthcare professional.
2. The vaccine is given as an injection under the skin (subcutaneous route), typically in the upper arm or thigh.
3. The primary vaccination course usually involves two doses, given according to national immunization guidelines (e.g., first dose around 12-15 months of age, second dose around 4-6 years of age).
4. Always follow the specific dosing schedule and advice provided by your doctor or healthcare provider.

Caution & Warnings:

• PRIORIX should not be administered to pregnant women. Pregnancy should be avoided for at least one month after vaccination.
• Individuals with a history of severe allergic reaction (anaphylaxis) to any component of the vaccine or a previous dose of PRIORIX should not receive it.
• The vaccine is contraindicated in individuals with primary or acquired immunodeficiency states (e.g., severe combined immunodeficiency, AIDS, leukemia, lymphoma, or those receiving immunosuppressive therapy).
• Consult your doctor if you have a history of seizures, bleeding disorders, or any acute severe febrile illness.
• Temporary side effects may include fever, rash, swelling, or redness at the injection site. Serious allergic reactions are rare but require immediate medical attention.

Ingredients:

• Each 0.5 mL dose contains:
• Measles virus (Schwarz strain) live attenuated, not less than 1000 CCID50
• Mumps virus (RIT 4385 strain) live attenuated, not less than 320 CCID50
• Rubella virus (Wistar RA 27/3 strain) live attenuated, not less than 1000 CCID50
• Excipients: Amino acids, lactose anhydrous, mannitol, sorbitol, water for injections. Traces of neomycin sulfate may be present.

Product Details:

• Brand: PRIORIX
• Manufacturer: GlaxoSmithKline (GSK)
• Drug Type: Prescription Vaccine
• Form: Powder and solvent for solution for injection (reconstituted to 0.5mL)
• Administration Route: Subcutaneous (SC)
• Package Size: 1 Vial
• Storage: Store in a refrigerator (2°C - 8°C). Do not freeze. Protect from light.